InflaRx Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Niels Riedemann

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure18yrs
CEO ownership1.8%
Management average tenure4yrs
Board average tenure5.7yrs

Recent management updates

Recent updates


CEO

Niels Riedemann (51 yo)

18yrs

Tenure

Prof. Dr. Niels C. Riedemann, M.D. is Chief Executive Officer of InflaRx N.V. since 2007 and serves as its Executive Director. Dr. Riedemann founded InflaRx N.V. in 2007 as InflaRx GmbH. Dr. Riedemann spen...


Leadership Team

NamePositionTenureCompensationOwnership
Niels Riedemann
Co-Founder18yrsno data1.82%
€ 2.5m
Renfeng Guo
Co-Founder18yrsno data2.99%
€ 4.1m
Thomas Taapken
Chief Financial Officer4.3yrsno data0.0059%
€ 8.2k
Derval O'Carroll
Senior VP and Global Head of Regulatory Affairs & Compliance1.8yrsno datano data
Camilla Chong
Chief Medical Officer1.5yrsno datano data
Jan Medina
Head of Investor Relations & VPless than a yearno datano data
Christian Schmid
VP and Head of Legal Affairs & General Counselno datano datano data
Nicole Bertsch
Senior Director & Head of Human Resources3.8yrsno datano data
Maria Habel
VP, Head of Preclinical R&D and QC12yrsno datano data
Bruce Burnett
VP & Head of Medical Affairsno datano datano data
Kofi Boaten
Senior Director and Head of Supply Quality & Clinical Trial Suppliesno datano datano data
Peter Hurt
Senior Director and Head of Drug Safety & Pharmacovigilianceno datano datano data

4.0yrs

Average Tenure

56yo

Average Age

Experienced Management: IF0's management team is considered experienced (4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Niels Riedemann
Co-Founderno datano data1.82%
€ 2.5m
Renfeng Guo
Co-Founderno datano data2.99%
€ 4.1m
Nicolas Fulpius
Independent Chairman of the Board18yrsno data0.79%
€ 1.1m
K. Reinhart
Member of Scientific Advisory Boardno datano datano data
P. Ward
Member of Scientific Advisory Boardno datano datano data
Richard Brudnick
Independent Non-Executive Director5.7yrsno data0.085%
€ 116.9k
Hege Hellstrom
Non-Executive Director1.8yrsno datano data
Mark Kubler
Independent Non-Executive Director10yrsno data1.63%
€ 2.2m
Anthony Gibney
Independent Non-Executive Director3.7yrsno data0.017%
€ 23.4k

5.7yrs

Average Tenure

53yo

Average Age

Experienced Board: IF0's board of directors are considered experienced (5.7 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/04 23:58
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

InflaRx N.V. is covered by 12 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Madhu KumarBaird
Mayur SomaiyaBMO Capital Markets Equity Research
Madhu KumarB. Riley Securities, Inc.